Evidence map›Paper›PMID 35852739›Full record

SynthesisCellular and molecular neurobiology2023

Traumatic MicroRNAs: Deconvolving the Signal After Severe Traumatic Brain Injury.

Martin Cente, Katarina Matyasova, Nikoleta Csicsatkova, Adela Tomikova, Sara Porubska, Yun Niu, Marek Majdan, Peter Filipcik, Igor Jurisica

Open access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Cellular and molecular neurobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Martin Cente *Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia.
Katarina Matyasova *Institute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia.
Nikoleta CsicsatkovaInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia.
Adela TomikovaInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia.
Sara PorubskaInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia.
Yun NiuDivision of Orthopaedic Surgery, Schroeder Arthritis Institute, and Data Science Discovery Centre, Osteoarthritis Research Program, Krembil Research Institute, UHN, Toronto, Canada.
Marek MajdanDepartment of Public Health, Faculty of Health Sciences and Social Work, Trnava University, Trnava, Slovakia.
Peter FilipcikInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia. peter.filipcik@savba.sk.
Igor JurisicaInstitute of Neuroimmunology, Slovak Academy of Sciences, Dúbravská cesta 9, 845 10 Bratislava 45, Bratislava, Slovakia. juris@ai.utoronto.ca.ORCID http://orcid.org/0000-0002-2507-946X
Slovak Academy of Sciences · SKDiscovery Centre · CAInstitute of Chemistry of the Slovak Academy of Sciences · SKUniversity Health Network · CAUniversity of Trnava · SK

Funding

Ontario Research Foundation 34876
6 · The paper itself

Abstract

History of traumatic brain injury (TBI) represents a significant risk factor for development of dementia and neurodegenerative disorders in later life. While histopathological sequelae and neurological diagnostics of TBI are well defined, the molecular events linking the post-TBI signaling and neurodegenerative cascades remain unknown. It is not only due to the brain's inaccessibility to direct molecular analysis but also due to the lack of well-defined and highly informative peripheral biomarkers. MicroRNAs (miRNAs) in blood are promising candidates to address this gap. Using integrative bioinformatics pipeline including miRNA:target identification, pathway enrichment, and protein-protein interactions analysis we identified set of genes, interacting proteins, and pathways that are connected to previously reported peripheral miRNAs, deregulated following severe traumatic brain injury (sTBI) in humans. This meta-analysis revealed a spectrum of genes closely related to critical biological processes, such as neuroregeneration including axon guidance and neurite outgrowth, neurotransmission, inflammation, proliferation, apoptosis, cell adhesion, and response to DNA damage. More importantly, we have identified molecular pathways associated with neurodegenerative conditions, including Alzheimer's and Parkinson's diseases, based on purely peripheral markers. The pathway signature after acute sTBI is similar to the one observed in chronic neurodegenerative conditions, which implicates a link between the post-sTBI signaling and neurodegeneration. Identified key hub interacting proteins represent a group of novel candidates for potential therapeutic targets or biomarkers.

Indexed as

Brain InjuriesBrain Injuries, TraumaticMicroRNAsNeurodegenerative DiseasesBiomarkersChronic DiseaseHumansBiomarkersMicroRNAsmiRNANeurodegenerationSevere traumatic brain injurySignaling pathwaysTBI

Identifiers

PMID35852739
PMCPMC11414451
OpenAlexW4285795838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.